![José Ángel Martinez Escribano](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
José Ángel Martinez Escribano
Oprichter bij Algenex SL
Oorsprong van het eerstegraads netwerk van José Ángel Martinez Escribano
Entiteit | Type entiteit | Industrie | |
---|---|---|---|
Algenex SL
![]() Algenex SL BiotechnologyHealth Technology Algenex SL develops and manufactures recombinant proteins. It specializes in the baculovirus vector-based innovative technologies to manufacture recombinant proteins used to produce vaccines, diagnostic reagents and therapeutic molecules. The company was founded by Jose Angel Martinez Escribano and Covadonga Alonso on January 19, 2005 and is headquartered in Pozuelo de Alarcon, Spain.
7
| Subsidiary | Biotechnology | 7 |
Grafiek van bedrijven verbonden in de tweede graad
Connectie in verschillende bedrijven
Bedrijven verbonden met José Ángel Martinez Escribano via zijn persoonlijke netwerk
Onderneming | Sector | Gelieerde personen | Hoofdpost |
---|---|---|---|
Universidad Complutense de Madrid | College/University | Undergraduate Degree Graduate Degree | |
Instituto de Empresa SL | College/University | Graduate Degree Masters Business Admin | |
3i Private Equity
![]() 3i Private Equity Investment ManagersFinance 3i Private Equity is a private equity firm, founded in 1945. The firm is headquartered in London, United Kingdom with additional offices around the world. | Investment Managers | Private Equity Investor | |
National University of Argentina | College/University | Undergraduate Degree | |
Hochschule Reutlingen | College/University | Undergraduate Degree | |
Instituto Catolico de Administracion y Direccion de Empresas | College/University | Undergraduate Degree | |
Portigon AG
![]() Portigon AG Regional BanksFinance Portigon AG engages in the management of its own assets. It also provides financial services and conducts banking activities. The company was founded in 1969 and is headquartered in Duesseldorf, Germany. | Regional Banks | Corporate Officer/Principal | |
Cellerix SA
![]() Cellerix SA Pharmaceuticals: GenericHealth Technology Founded in 2004, Cellerix is a biopharmaceutical company that develops innovative treatments based on cell therapy. Cellerix was founded within the Genetrix Group, group of biotechnology companies specialising in biomedicine. The Genetrix Group began its activities in 2001 at the National Centre for Biotechnology (CNB), which belongs to the Spanish Research Council (CSIC). One of the main objectives of Genetrix is to convert basic research results into therapeutic realities. Cellerix is leading the development of a new generation of medicines using expanded adult stem cells from adipose tissue (eASCs). Development is at a clinically advanced stage and the results from clinical trials in Phase I and II have been very promising. Obtaining these eASCs has big advantages because the process makes use of tissue that is almost always discarded from surgical procedures such as liposuction. eASCs have the capacity to activate physiological repair mechanisms through interaction with affected tissue. This technology represents a revolution in the treatment of some diseases that cannot satisfactorily be cured at present. Cellerix is working actively to adapt this new therapeutic strategy to treat autoimmune diseases such as inflammatory bowel disease. The main goal of the company is to market new tools for treating these diseases, which have a considerable negative impact of the quality of life of the sufferers. Cellerix also researches and develops medicines in other areas such as the development of skin equivalents, which are initially intended for the treatment of hereditary diseases such as epidermolysis bullosa. | Pharmaceuticals: Generic | Corporate Officer/Principal | |
Auropean Ventures, Inc.
![]() Auropean Ventures, Inc. Precious MetalsNon-Energy Minerals Auropean Ventures, Inc. operates as a private company focused on the exploration and development of gold and polymetallic projects. The firm has projects in Spain, Slovakia and Yukon. The company is headquartered in Carp, Canada. | Precious Metals | Director/Board Member | |
SNIACE, S.A. | Chemicals: Specialty | Corporate Secretary | |
Biocontrol Technologies SL
![]() Biocontrol Technologies SL BiotechnologyHealth Technology Biocontrol Technologies. SL develops and produces microorganisms as pest control agents. The firm offers T-34 Biocontrol product. It services include analysis of pathogen populations, specific seminars for formers and advisers in different fields to improve plant growth. The company was founded by Francesc Peremiquel Lluch in 2004 and is headquartered in Barcelona, Spain. | Biotechnology | Director/Board Member | |
Immunostep SL
![]() Immunostep SL Medical SpecialtiesHealth Technology Immunostep SL develops and manufactures cell reagents. The firms manufacture and commercialization of cell culture reagents for use in flow cytometry diagnosis and clinical research. Its services include polyclonal development, contract services, price list service, monoclonal development, chicken polyclonal development, rabbit polyclonal development. The company was founded by Ricardo Jara Acevedo, Jose Claros Parra and Alfredo Conde Alonso in September 2001 and is headquartered in Salamanca, Spain. | Medical Specialties | Director/Board Member | |
Ascom Spain SA | Chief Executive Officer | ||
Unirisco Galicia
![]() Unirisco Galicia Investment ManagersFinance UNIRISCO Galicia (UNIRISCO) is an independent Spanish venture capital firm which was formed in 2000 as part of a University of Santiago de Compostela initiative to promote the creation of companies making use of technology research emanating from the University of Santiago and the University of Vigo. Based in Santiago de Compostela, UNIRISCO facilitates direct contact between major R&D centres in Galicia, allowing access to the university research groups and their scientific production skills. They also provide investee companies with consultancy services and access to their network of partners. | Investment Managers | Chief Operating Officer | |
vasopharm GmbH
![]() vasopharm GmbH Pharmaceuticals: MajorHealth Technology vasopharm GmbH operates as a pharmaceutical company. It discovers and develops novel therapeutics for the treatment of cerebro and cardiovascular diseases and their consequences. The firm focuses on therapeutics influencing the bioavailability of nitric oxide. The company was founded by Harald Schmidt and Ulrich Walter in July 1998 and is headquartered in Wuerzburg, Germany. | Pharmaceuticals: Major | Director/Board Member | |
Uninvest SGEIC SA
![]() Uninvest SGEIC SA Investment ManagersFinance Uninvest SGEIC SA (Uninvest) is a venture capital firm founded in 2005. The firm is headquartered in Santiago de Compostela, Spain. | Investment Managers | Chief Operating Officer | |
Cleon Capital Advisors SL
![]() Cleon Capital Advisors SL Investment ManagersFinance Cleon Capital Advisors SL (Cleon Capital Advisors) is a private equity firm founded in 2015 by Nicola Zambon. The firm is headquartered in Madrid, Spain with additional office in Milan. | Investment Managers | Consultant / Advisor | |
Greenhill & Co. Spain Ltd.
![]() Greenhill & Co. Spain Ltd. Investment ManagersFinance Part of Greenhill & Co., Inc., Greenhill & Co. Spain Ltd. is a Spanish company that provides financial advisory services. The company is based in Madrid, Spain. | Investment Managers | Private Equity Investor | |
GAIN THERAPEUTICS, INC. | Biotechnology | Director/Board Member | |
Pregimmune Corp.
![]() Pregimmune Corp. Medical/Nursing ServicesHealth Services Pregimmune Corp. is a private company based in Dover, DE. The company specializes in developing novel immunotherapies for pregnancy-related complications. The company's research focuses on understanding the immune system's role in pregnancy and developing therapies to prevent or treat complications such as preeclampsia, preterm birth, and fetal growth restriction. | Medical/Nursing Services | Director/Board Member | |
Medinet Clinical Services Ltd.
![]() Medinet Clinical Services Ltd. Medical/Nursing ServicesHealth Services Part of Medinet Topco Ltd., Medinet Clinical Services Ltd. is a leading provider of specialised clinical teams delivering additional elective services to the NHS. The company is based in Sutton Coldfield, UK. The British company offers fully managed specialised clinical teams to help reduce NHS waiting times throughout the UK, including urology and general surgery insourcing. The company was founded in 2005 with the intention of easing the pressure on the NHS service, so that it can see and treat more patients. | Medical/Nursing Services | Director/Board Member | |
Medinet Bidco Ltd. | Miscellaneous | Director/Board Member | |
Medinet Midco II Ltd.
![]() Medinet Midco II Ltd. Financial ConglomeratesFinance Part of Medinet Topco Ltd., Medinet Midco II Ltd. functions as an investment holding British company. The company is based in Sutton Coldfield, UK and was founded in 2016. | Financial Conglomerates | Director/Board Member | |
Medinet Midco I Ltd.
![]() Medinet Midco I Ltd. Medical/Nursing ServicesHealth Services Part of Medinet Topco Ltd., Medinet Midco I Ltd. is a provider of specialised clinical teams that deliver additional elective services to the NHS. The company is based in Sutton Coldfield, UK. Medinet Midco I offers urology and dermatology insourcing services, as well as fully managed specialised clinical teams. The British company was founded in 2016 and has been helping to reduce NHS waiting times for 15 years. | Medical/Nursing Services | Director/Board Member | |
Fort Rock Capital Ltd.
![]() Fort Rock Capital Ltd. Financial ConglomeratesFinance Fort Rock Capital Ltd. provides investment services. The company is headquartered in London, the United Kingdom. | Financial Conglomerates | Director/Board Member | |
University of Bocconi | College/University | Undergraduate Degree | |
The Wharton School of the University of Pennsylvania | College/University | Masters Business Admin | |
University of Uppsala | College/University | Doctorate Degree |
Statistieken
Internationaal
Spanje | 16 |
Verenigd Koninkrijk | 7 |
Duitsland | 4 |
Verenigde Staten | 4 |
Canada | 3 |
Sectoraal
Consumer Services | 9 |
Finance | 9 |
Health Technology | 8 |
Health Services | 4 |
Non-Energy Minerals | 3 |
Operationeel
Director/Board Member | 17 |
Undergraduate Degree | 5 |
Corporate Officer/Principal | 4 |
Private Equity Investor | 3 |
Chief Executive Officer | 3 |
Sterkste connecties
- Beurs
- Insiders
- José Ángel Martinez Escribano
- Bedrijfsconnecties